← Back to all trials
Not Yet Recruiting
NCT07775196
Aging and Exercise Impacts on Glymphatic Function
Conditions: Aging and Exercise Impacts on Glymphatic Function
Sex: All
Ages: 25 Years – 75 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 240
Sponsor: University of Texas Southwestern Medical Center
Summary
This is a prospective, interventional, non-blinded, single center research project that will recruit cognitively unimpaired subjects in the 25-55 year old and 55-75 year old range. This study will use acute aerobic exercise as a natural intervention model to increase cardiac activity which may further drive the glymphatic function. There will be no randomization, and all enrolled subjects will participate in the exercise session.
Hypotheses: revealed by the multi-modal magnetic resonance imaging (MRI) approach, glymphatic dysfunction increases with age and is associated with preclinical Alzheimer's Disease (AD) pathology in cognitively unimpaired individuals. Using acute aerobic exercise as a human model, the enhancement of cerebrospinal fluid-interstitial fluid (CSF-ISF) exchange caused by elevated cardiac activity and paravascular cerebrospinal fluid (pCSF) dynamics can be validated.
Eligibility Criteria
Inclusion Criteria:
* age 25-75 years old
* cognitively unimpaired (CU)
* Mini-Mental State Examination (MMSE) score ≥27 at enrollment screening
* matched gender
* all racial/ethnic groups
Exclusion Criteria:
* pregnant women
* history of stroke or other major cerebrovascular disease;
* diagnosis of Alzheimer's disease (AD) or other types of dementia;
* diagnosis of major neurologic and psychiatric disorders (e.g., Parkingson's disease, major depression);
* history of prior head trauma, significant autoimmune disorders,
* sleep apnea;
* major systemic illness likely to affect the central nervous system, e.g., uncontrolled diabetes, severe cardiovascular disease, cancer, etc.;
* prior or current alcoholism or drug abuse;
* resistant hypertension (SBP ≥140 or DBP ≥ 90 mmHg despite 3 antihypertensive drugs at maximal doses);
* orthostatic hypotension defined as the third standing systolic blood pressure (SBP) \< 100mmHg; any contraindications to having a MRI, e.g., claustrophobia, pacemaker or other medical device of metal;
* any conditions judged by the investigators to be medically inappropriate, risky or likely to cause poor study compliance.
Source: ClinicalTrials.gov (NCT07775196). StuddyBuddy aggregates publicly available trial information.